Skip to main content

Tweets

Join us tonight at 6pm PT/ 9pm ET for our daily #ACR23 recap. https://t.co/0RDwTdzhwS
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
Following on from the #ACR23 keynote, a deeper dive on how AI might actually help clinical rheumatologists in real life, from clinical rheumatologist @DrCMcMaster @DT4Health et al in @ACR_Journals: https://t.co/dQJzTwScy0 @RheumNow

David Liew @drdavidliew ( View Tweet )

2 years 3 months ago
#ACR23 Abs #0505 found use of IL-17 inhibitors and oral DMARD alone were associated with a decreased likelihood of achieving MDA in PsA. Small sample size, but interesting finding nonetheless. https://t.co/CAZGykwxRT @rheumnow https://t.co/8ptF8aTIFu
Dr. Rachel Tate ( View Tweet )
2 years 3 months ago
💡RP is a heterogeneous disease. 💡Think VEXAS in RP with MDS. 💡Think MAGIC if oral/genital ulcers. 💡Pts are experts on their own disease! Listen and acknowledge their symptoms. Shout out to Dr @maferradastrong #ACR23 #ImNotYellingImColombian🇨🇴 @ACRheum @RheumNow https://t.co/nTZ96pJh09
Adela Castro @AdelaCastro222 ( View Tweet )
2 years 3 months ago
💡Screen pts with Ssc for ILD with HRCT at diagnosis. 💡“MCTD” may meet criteria for Ssc dont look away at the positive U1RNP! 💡Kidney biopsy in SRC =Time is of the essence. 💡Cardiac involvement is 2nd cause of mortality screen with echo annually. @fboinMD #ACR23 @RheumNow https://t.co/yp3yjqqeQv
Adela Castro @AdelaCastro222 ( View Tweet )
2 years 3 months ago
How can we maximise digital health to improve outcomes. Come and visit my poster session today and it will be good to meet IRL. I’m presenting poster #0507 using digital e-PROMs to measure disease activity in psoriatic arthritis #digital Abst #0507 #ACR23 @RheumNow https://t.co/R9LX8H9X0E
Dr. Antoni Chan ( View Tweet )
2 years 3 months ago
#ACR23 Abs 0484 found higher hs-CRP levels helped identify PsO pts at high risk of future development of PsA. Unclear timeline, but this may help to early ID referrals to rheum. https://t.co/4JRsI6iEgI @rheumnow https://t.co/sXNwyL87Ud
Dr. Rachel Tate ( View Tweet )
2 years 3 months ago
Pain, itch, and fatigue associated with decreased work productivity/impairment in PsA and PsO pts. #ACR23 considerations for treatment for these pts should include these factors. Abs #0488 https://t.co/mLG5ohFopQ @rheumnow https://t.co/8ANL4pcxM2
Dr. Rachel Tate ( View Tweet )
2 years 3 months ago
#ACR23 Abstr#PP12 "I am stronger than my disease & won’t let it stop me from leading a fulfilling life!"- a person with #Sjogren shared tips on lifestyle modification to help fatigue. - schedule appointments in the morning - exercise - keep a diary - listen to body @RheumNow https://t.co/8ROFrDvPS1
Md Yuzaiful Md Yusof ( View Tweet )
2 years 3 months ago
Do you check fecal calprotectin levels in your SpA pts? Maybe you should. #ACR23 Abs #0495 EISER study shows increased prevalence of undiagnosed IBD in SpA that may be detected in our clinics with fecal calprotectin levels prior to GI evaluation. https://t.co/d7BbrUd570 @rheumnow https://t.co/COcKdvjWnr
Dr. Rachel Tate ( View Tweet )
2 years 3 months ago
RheumNow’s expanded coverage of the #ACR23 Annual meeting is sponsored in part by Bristol Myers Squibb and UCB. All content is chosen by RheumNow & its faculty

Dr. John Cush @RheumNow ( View Tweet )

2 years 3 months ago
AI is here to stay, like it or not. Some words to ponder on👇 #ACR23 @RheumNow @rheumarhyme https://t.co/2K3Qc0Il8i
sheila ( View Tweet )
2 years 3 months ago
×